The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.
Article obtained from Photonics RSS Feed.
Jenoptik concluded the first half of its year with a reported revenue of €329 million ($389.9 million), a year-over-year decrease of 14.1%. For the quarter, the company’s revenue dropped 17.4% to €164.6 million ($194.3 million).
Compared to 2019, earnings per share fell 56.6% for the six-month period ending in June 2020, and 22.8% for the quarter. Quarterly earnings per share reached €0.19 ($0.23).
“After a solid start to the year, the second quarter has seen a weaker order situation, as we expected,” said Stefan Traeger, Jenoptik president and CEO. “However, we are confident of achieving improved business performance in the second half-year. Key to this has been our comprehensive and…READ MORE